VNS therapy reverses the reduction in connexin-43 mRNA and protein expression associated with HF [76], providing strong supportive, yet indirect, evidence that VNS may have anti-arrhythmogenic properties in the failing heart. Here, GJA1 is linked to hydrops fetalis.